Shenzhen Kangtai Biological Products Co Ltd
SZSE:300601
Shenzhen Kangtai Biological Products Co Ltd
SZSE:300601
Price:
15.57
CNY
-0.19%
Market Cap:
¥17.4B
Cash Flow Statement
Cash Flow Statement
Shenzhen Kangtai Biological Products Co Ltd
Shenzhen Kangtai Biological Products Co Ltd
Currency: CNY
| Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||||||||||||||||||||||
| Cash Taxes Paid |
(49)
|
(39)
|
(40)
|
(43)
|
(57)
|
(48)
|
(67)
|
(80)
|
(120)
|
(164)
|
(163)
|
(181)
|
(156)
|
(147)
|
(171)
|
(163)
|
(115)
|
(125)
|
(150)
|
(160)
|
(63)
|
(65)
|
(39)
|
(60)
|
(215)
|
(206)
|
(186)
|
(130)
|
(100)
|
(82)
|
(86)
|
(105)
|
(110)
|
(114)
|
(123)
|
(129)
|
(133)
|
(129)
|
|
| Change in Working Capital |
(132)
|
(120)
|
(182)
|
(215)
|
(316)
|
(440)
|
(543)
|
(638)
|
(743)
|
(846)
|
(1 023)
|
(1 091)
|
(1 107)
|
(1 069)
|
(945)
|
(901)
|
(868)
|
(489)
|
(747)
|
(828)
|
(876)
|
(1 231)
|
(972)
|
(968)
|
(1 068)
|
(1 207)
|
(1 222)
|
(1 310)
|
(1 374)
|
(1 499)
|
(1 656)
|
(1 760)
|
(1 761)
|
(1 714)
|
(1 700)
|
(1 703)
|
(1 732)
|
(1 664)
|
|
| Cash from Operating Activities |
272
N/A
|
165
-39%
|
78
-53%
|
41
-48%
|
35
-15%
|
99
+185%
|
154
+55%
|
202
+31%
|
278
+37%
|
281
+1%
|
337
+20%
|
326
-3%
|
387
+19%
|
446
+15%
|
506
+13%
|
441
-13%
|
407
-8%
|
747
+83%
|
440
-41%
|
337
-23%
|
463
+37%
|
891
+92%
|
1 652
+85%
|
1 770
+7%
|
1 711
-3%
|
953
-44%
|
546
-43%
|
735
+35%
|
777
+6%
|
911
+17%
|
1 033
+13%
|
828
-20%
|
751
-9%
|
644
-14%
|
603
-6%
|
633
+5%
|
621
-2%
|
730
+17%
|
|
| Investing Cash Flow | |||||||||||||||||||||||||||||||||||||||
| Capital Expenditures |
(205)
|
(160)
|
(172)
|
(164)
|
(169)
|
(170)
|
(190)
|
(219)
|
(264)
|
(313)
|
(344)
|
(439)
|
(410)
|
(364)
|
(387)
|
(286)
|
(442)
|
(668)
|
(1 227)
|
(1 556)
|
(1 825)
|
(2 240)
|
(2 540)
|
(2 600)
|
(2 460)
|
(2 014)
|
(1 310)
|
(1 061)
|
(890)
|
(790)
|
(718)
|
(700)
|
(619)
|
(568)
|
(472)
|
(409)
|
(356)
|
(296)
|
|
| Other Items |
14
|
10
|
(6)
|
(2)
|
1
|
(43)
|
(71)
|
(72)
|
(10)
|
(26)
|
108
|
4
|
3
|
(87)
|
7
|
(4)
|
(2 221)
|
(1 512)
|
(2 610)
|
(2 012)
|
791
|
526
|
1 100
|
649
|
(22)
|
(1 405)
|
(1 296)
|
(1 084)
|
(1 306)
|
(37)
|
280
|
(154)
|
236
|
(47)
|
(85)
|
164
|
92
|
971
|
|
| Cash from Investing Activities |
(191)
N/A
|
(149)
+22%
|
(178)
-19%
|
(166)
+6%
|
(168)
-1%
|
(213)
-27%
|
(261)
-23%
|
(291)
-12%
|
(274)
+6%
|
(339)
-24%
|
(236)
+30%
|
(436)
-84%
|
(408)
+6%
|
(451)
-11%
|
(380)
+16%
|
(291)
+23%
|
(2 663)
-816%
|
(2 180)
+18%
|
(3 837)
-76%
|
(3 568)
+7%
|
(1 034)
+71%
|
(1 715)
-66%
|
(1 440)
+16%
|
(1 952)
-36%
|
(2 482)
-27%
|
(3 420)
-38%
|
(2 606)
+24%
|
(2 145)
+18%
|
(2 195)
-2%
|
(827)
+62%
|
(439)
+47%
|
(854)
-95%
|
(383)
+55%
|
(616)
-61%
|
(557)
+10%
|
(244)
+56%
|
(264)
-8%
|
675
N/A
|
|
| Financing Cash Flow | |||||||||||||||||||||||||||||||||||||||
| Net Issuance of Debt |
(121)
|
29
|
85
|
40
|
1
|
(55)
|
(56)
|
312
|
320
|
343
|
360
|
40
|
(1)
|
(49)
|
(49)
|
(80)
|
(308)
|
(230)
|
(165)
|
143
|
620
|
2 835
|
3 115
|
2 488
|
2 196
|
(163)
|
(541)
|
(171)
|
(112)
|
23
|
80
|
186
|
(365)
|
(390)
|
(531)
|
(769)
|
(313)
|
(330)
|
|
| Cash Paid for Dividends |
(32)
|
(18)
|
(18)
|
(12)
|
(42)
|
(44)
|
(43)
|
(42)
|
(62)
|
(67)
|
(64)
|
(65)
|
(23)
|
(176)
|
(178)
|
(177)
|
(174)
|
(211)
|
(207)
|
(205)
|
(207)
|
(215)
|
(220)
|
(225)
|
(821)
|
(623)
|
(622)
|
(622)
|
(31)
|
(35)
|
(237)
|
(237)
|
(455)
|
(461)
|
(257)
|
(252)
|
(126)
|
(134)
|
|
| Other |
(12)
|
(14)
|
(11)
|
105
|
112
|
249
|
246
|
160
|
170
|
33
|
36
|
14
|
10
|
14
|
0
|
0
|
2 974
|
2 970
|
4 151
|
4 277
|
1 323
|
883
|
(442)
|
(251)
|
119
|
541
|
698
|
121
|
(282)
|
(261)
|
(261)
|
(13)
|
(1)
|
(13)
|
(14)
|
(2)
|
(14)
|
9
|
|
| Cash from Financing Activities |
(165)
N/A
|
(3)
+98%
|
56
N/A
|
133
+137%
|
71
-47%
|
150
+113%
|
147
-2%
|
430
+193%
|
429
0%
|
309
-28%
|
332
+7%
|
(12)
N/A
|
(13)
-12%
|
(211)
-1 525%
|
(227)
-7%
|
(264)
-16%
|
2 492
N/A
|
2 530
+2%
|
3 779
+49%
|
4 215
+12%
|
1 736
-59%
|
3 503
+102%
|
2 452
-30%
|
2 012
-18%
|
1 494
-26%
|
(244)
N/A
|
(465)
-90%
|
(671)
-44%
|
(425)
+37%
|
(274)
+36%
|
(418)
-53%
|
(65)
+85%
|
(822)
-1 172%
|
(864)
-5%
|
(801)
+7%
|
(1 022)
-28%
|
(453)
+56%
|
(455)
0%
|
|
| Change in Cash | |||||||||||||||||||||||||||||||||||||||
| Effect of Foreign Exchange Rates |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(1)
|
(3)
|
(3)
|
(3)
|
(2)
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Net Change in Cash |
(84)
N/A
|
14
N/A
|
(43)
N/A
|
8
N/A
|
(62)
N/A
|
37
N/A
|
40
+9%
|
341
+753%
|
432
+27%
|
251
-42%
|
432
+72%
|
(122)
N/A
|
(33)
+73%
|
(217)
-549%
|
(101)
+54%
|
(113)
-12%
|
237
N/A
|
1 096
+363%
|
382
-65%
|
984
+158%
|
1 165
+18%
|
2 680
+130%
|
2 663
-1%
|
1 827
-31%
|
720
-61%
|
(2 714)
N/A
|
(2 527)
+7%
|
(2 081)
+18%
|
(1 843)
+11%
|
(190)
+90%
|
176
N/A
|
(90)
N/A
|
(454)
-402%
|
(837)
-84%
|
(754)
+10%
|
(634)
+16%
|
(95)
+85%
|
950
N/A
|
|
| Free Cash Flow | |||||||||||||||||||||||||||||||||||||||
| Free Cash Flow |
67
N/A
|
6
-91%
|
(93)
N/A
|
(123)
-32%
|
(134)
-9%
|
(70)
+47%
|
(36)
+49%
|
(17)
+53%
|
13
N/A
|
(31)
N/A
|
(7)
+77%
|
(114)
-1 481%
|
(23)
+80%
|
82
N/A
|
119
+45%
|
155
+30%
|
(35)
N/A
|
78
N/A
|
(787)
N/A
|
(1 219)
-55%
|
(1 361)
-12%
|
(1 349)
+1%
|
(888)
+34%
|
(831)
+6%
|
(749)
+10%
|
(1 062)
-42%
|
(765)
+28%
|
(326)
+57%
|
(112)
+65%
|
121
N/A
|
315
+161%
|
128
-59%
|
133
+4%
|
75
-43%
|
131
+74%
|
224
+71%
|
266
+18%
|
433
+63%
|
|
Switch to:
Switch to:
See Also
Discover More
